• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Trevena, Inc. (TRVN)

    -NasdaqGS
    5.54 Up 0.28(5.32%) Mar 5, 4:00PM EST
    Add to Portfolio
    Prev Close:5.26
    Open:5.28
    Bid:5.55 x 200
    Ask:N/A
    1y Target Est:17.00
    Beta:N/A
    Earnings Date:Mar 18 - Mar 23 (Est.)
    Day's Range:5.31 - 5.54
    52wk Range:3.80 - 9.64
    Volume:137,401
    Avg Vol (3m):123,535
    Market Cap:208.45M
    P/E (ttm):N/A
    EPS (ttm):-2.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TRVN

    Comparison

    Symbol% ChgMkt Cap
    TRVNUp 5.32%208.45M
    CYTKDown 0.50%290.68M
    NVSDown 0.09%237.34B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.11
    Quarterly EPS Est (Dec-14) :-0.52
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback